Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors
Clinical trial NCT01548924 · TERMINATED
Trial details
- NCT number
- NCT01548924
- Sponsor
- Centro Nacional de Investigaciones Oncologicas CARLOS III
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.